The invention relates to the use of one or more antimicrobial metals selected from silver, gold, platinum, and palladium but most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of a acne. The nanocrystalline antimicrobial metal
The invention relates to the use of one or more antimicrobial metals selected from silver, gold, platinum, and palladium but most preferably silver, preferably formed with atomic disorder, and preferably in a nanocrystalline form, for the treatment of a acne. The nanocrystalline antimicrobial metal of choice may be used in the form of a nanocrystalline coating of one or more antimicrobial metals, a nanocrystalline powder of one or more antimicrobial metals, or a solution containing dissolved species from a nanocrystalline powder or coating of one or more antimicrobial metals.
대표청구항▼
We claim: 1. A method of treating acne conditions, the method comprising: contacting an acne problem area of a patient with a therapeutically effective amount of one or more antimicrobial metals in a nanocrystalline form to provide a localized antimicrobial and anti-inflammatory effect, wherein: th
We claim: 1. A method of treating acne conditions, the method comprising: contacting an acne problem area of a patient with a therapeutically effective amount of one or more antimicrobial metals in a nanocrystalline form to provide a localized antimicrobial and anti-inflammatory effect, wherein: the one or more antimicrobial metals in nanocrystalline form have sufficient atomic disorder so that the one or more antimicrobial metals in nanocrystalline form, when in contact with an alcohol or water-based electrolyte, releases atoms, ions, molecules, or clusters of the one or more antimicrobial metals in nanocrystalline form into the alcohol or water-based electrolyte on a sustainable basis and at a concentration sufficient to provide a localized antimicrobial and anti-inflammatory effect; and the one or more antimicrobial metals are provided as a coating on, or filler in, a dressing, or in a pharmaceutical composition with one or more pharmaceutically and dermatologically acceptable carriers, diluents or excipients suitable for topical administration. 2. The method as set forth in claim 1, wherein the antimicrobial metal is nanocrystalline silver, wherein nanocrystalline indicates a grain size which is less than 100 nanometers in at least one dimension. 3. The method as set forth in claim 1, wherein the pharmaceutical composition includes a nanocrystalline powder of said one or more antimicrobial metals, or a solution containing dissolved species from a nanocrystalline powder or coating of said one or more antimicrobial metals. 4. The method as set forth in claim 3, wherein the pharmaceutical composition is a gel, cream or lotion containing the antimicrobial metal powder in an amount of 0.01-5% by weight, or a liquid containing 0.001-1% by weight of the antimicrobial metal. 5. The method as set forth in claim 1, wherein the coating is provided on a dressing. 6. The method as set forth in claim 5, wherein the coating is 15-3000 nm thick. 7. The method as set forth in claim 5, wherein the coating comprises: a base layer of partly reflective material capable of generating an interference color when covered with a partly reflective, partly light transmissive top layer; and a top layer formed over said base layer, said top layer being a partly reflective, partly light transmissive thin film containing at least one noble metal in nanocrystalline form and having a thickness so that a first or second order interference color is produced, said top layer having a refractive index different from that of said base layer, and the noble metal being formed with sufficient atomic disorder so that the top layer, in contact with an alcohol or water based electrolyte, releases ions, atoms, molecules or clusters of the noble metal into the alcohol or water based electrolyte on a sustainable basis. 8. The method as set forth in claim 7, wherein the dressing is fixed in place with an occlusive or semi-occlusive layer which maintains the dressing in a moist condition. 9. The method as set forth in claim 8, wherein the occlusive layer or semi-occlusive layer is an adhesive tape or film. 10. The method as set forth in claim 2, wherein the antimicrobial metal is nanocrystalline silver, wherein nanocrystalline indicates a grain size which is less than 50 nanometers in at least one dimension. 11. The method as set forth in claim 10, wherein the antimicrobial metal is nanocrystalline silver, wherein nanocrystalline indicates a grain size which is less than 25 nanometers in at least one dimension. 12. The method as set forth in claim 3, wherein the nanocrystalline powder includes particulates of the one or more antimicrobial metals having a particulate size which is less than 100 μ m. 13. The method as set forth in claim 12, wherein the nanocrystalline powder includes particulates of the one or more antimicrobial metals having a particulate size which is less than 40 μ m. 14. A method of treating acne conditions, comprising: contacting an acne problem area of a patient with a therapeutically effective amount of a pharmaceutical composition to provide a localized antimicrobial and anti-inflammatory effect, wherein: the pharmaceutical composition comprises: an antimicrobial metal in a nanocrystalline form; and one or more pharmaceutically and dermatologically acceptable carriers, diluents or excipients suitable for topical administration; and the antimicrobial metal in nanocrystalline form has sufficient atomic disorder so that the antimicrobial metal in nanocrystalline form, when in contact with an alcohol or water-based electrolyte, releases atoms, ions, molecules, or clusters of the metal into the alcohol or water-based electrolyte on a sustainable basis and at a concentration sufficient to provide a localized antimicrobial and anti-inflammatory effect. 15. The method as set forth in claim 14, wherein the pharmaceutical composition comprises a gel, cream or lotion containing the antimicrobial silver in a nanocrystalline form in an amount of 0.01 to 5% by weight. 16. The method as set forth in claim 14, wherein the antimicrobial metal in nanocrystalline form has a grain size of less than 100 nanometers in at least one dimension. 17. The method as set forth in claim 14, wherein the antimicrobial metal in nanocrystalline form has a grain size of less than 50 nanometers in at least one dimension. 18. The method as set forth in claim 14, wherein the antimicrobial metal in nanocrystalline form has a grain size of less than 25 nanometers in at least one dimension. 19. The method of claim 14, wherein the antimicrobial metal in nanocrystalline form is selected from the group consisting of antimicrobial silver in nanocrystalline form, antimicrobial gold in nanocrystalline form, antimicrobial platinum in nanocrystalline form, and antimicrobial palladium in nanocrystalline form. 20. The method according to claim 14, wherein the antimicrobial metal in nanocrystalline form comprises antimicrobial silver in nanocrystalline form.
Beerse Peter William ; Biedermann Kimberly Ann ; Page Steven Hardy ; Mobley Michael Joseph ; Morgan Jeffrey Michael, Antimicrobial compositions comprising a benzoic acid analog and a metal salt.
Oetjen Georg-Wilhelm (Lbeck DEX) Benthin Frank (Lbeck-Hamberge DEX), Humdifier and heater for air to be inhaled for connection to an inhalation conduit of a respirator.
Fox ; Jr. Charles L. (New York NY) Modak Shanta M. (River Edge NJ) Sampath Lester A. (Nyack NY), Infection-resistant compositions, medical devices and surfaces and methods for preparing and using same.
Fox ; Jr. Charles L. (Ft. Lauderdale FL) Modak Shanta (River Edge NJ) Reemtsma Keith (New York NY), Infection-resistant materials and method of making same through use of sulfonamides.
Gruskin Elliott A. (East Norwalk CT) Lee Daniel R. (Madison CT) Brown Lloyd S. (Guilford CT), Infection-resistant surgical devices and methods of making them.
Hampden-Smith Mark J. ; Kodas Toivo T. ; Powell Quint H. ; Skamser Daniel J. ; Caruso James ; Chandler Clive D., Method for making silver-containing particles.
De Cuellar Blanca Rosa A. (Mexico City MXX) Bello Luis Armando L. (Cuidad Satelite MXX), Method of manufacturing a composition for treating skin lesions.
McKinnon ; Jr. Charles N. (Laguna Niguel CA) Peterson Steven F. (West Linn OR) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection device.
Peterson Steven F. (West Linn OR) McKinnon ; Jr. Charles N. (Laguna Niguel CA) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection methods and device.
Peterson Steven F. (West Linn OR) McKinnon ; Jr. Charles N. (Laguna Niguel CA) Smith Paul E. (Tualatin OR) Nakagawa Takaaki (Tigard OR) Bartholomew Victor L. (Tigard OR), Needleless hypodermic injection methods and device.
Burrell Robert E. (Sherwood Park CAX) McIntosh Catherine L. (Sherwood Park CAX) Morris Larry R. (Yarker CAX), Process of activating anti-microbial materials.
Herb Craig A. ; Chen Liang Bin ; Chung Judy ; Long Michelle A. ; Sun Wei Mei ; Newell Gerald P. ; Evans Trefor A. ; Kamis Kimberly ; Brucks Richard M., Rinse-off water-in-oil-in-water compositions.
Vodyanoy, Vitaly J.; Scharpf, Jr., Lewis G.; Samoylov, Alexandre; Viswaprakash, Nilmini; Globa, Ludmila Petrovna; Morrison, Edward E., Compositions for and methods of controlling olfactory responses to odorants.
Vodyanoy, Vitaly J.; Scharpf, Lewis G.; Samoylov, Alexandre; Viswaprakash, Nilmini; Globa, Ludmila Petrovna; Morrison, Edward E., Compositions for and methods of controlling olfactory responses to odorants.
Choi, Jennifer Hagyoung Kang; Yang, Chunlin; Sun, Ying; Fang, Carrie H.; Hauschild, James E.; Creasey, Abla A., Medical devices with galvanic particulates.
Roszell, James A., Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.